BACKGROUND AND PURPOSE: Enlarged perivascular spaces (EPVSs) have been associated with relapses and brain atrophy in multiple sclerosis (MS). We investigated the association of EPVS with clinical and MRI features of disease worsening in a well-characterized cohort of relapsing-remitting MS patients prospectively followed for up to 10 years. METHODS: Baseline EPVSs were scored on 1.5T MRI in 30 converters to moderate-severe disability, and 30 nonconverters matched for baseline characteristics. RESULTS: EPVS scores were not significantly different between converters and nonconverters, nor associated with accrual of lesions or brain atrophy. CONCLUSIONS: Our preliminary findings from a relatively small study sample argue against a potential use of EPVS as early indicator of risk for disease worsening in relapsing-remitting MS patients in a clinical setting. Although the small sample size and clinical 1.5T MRI may have limited our ability to detect a significant effect, we provided estimates of the association of EPVS with clinical and MRI indicators of disease worsening in a well-characterized cohort of MS patients.
BACKGROUND AND PURPOSE: Enlarged perivascular spaces (EPVSs) have been associated with relapses and brain atrophy in multiple sclerosis (MS). We investigated the association of EPVS with clinical and MRI features of disease worsening in a well-characterized cohort of relapsing-remitting MSpatients prospectively followed for up to 10 years. METHODS: Baseline EPVSs were scored on 1.5T MRI in 30 converters to moderate-severe disability, and 30 nonconverters matched for baseline characteristics. RESULTS: EPVS scores were not significantly different between converters and nonconverters, nor associated with accrual of lesions or brain atrophy. CONCLUSIONS: Our preliminary findings from a relatively small study sample argue against a potential use of EPVS as early indicator of risk for disease worsening in relapsing-remitting MSpatients in a clinical setting. Although the small sample size and clinical 1.5T MRI may have limited our ability to detect a significant effect, we provided estimates of the association of EPVS with clinical and MRI indicators of disease worsening in a well-characterized cohort of MSpatients.
Authors: S C Kolbe; L M Garcia; N Yu; F M Boonstra; M Clough; B Sinclair; O White; A van der Walt; H Butzkueven; J Fielding; M Law Journal: AJNR Am J Neuroradiol Date: 2022-02 Impact factor: 3.825
Authors: Farshid Sepehrband; Ryan P Cabeen; Jeiran Choupan; Giuseppe Barisano; Meng Law; Arthur W Toga Journal: Neuroimage Date: 2019-04-30 Impact factor: 6.556
Authors: Mandip S Dhamoon; Ying-Kuen Cheung; Janet T DeRosa; Jose Gutierrez; Yeseon P Moon; Ralph L Sacco; Mitchell S V Elkind; Clinton B Wright Journal: J Am Geriatr Soc Date: 2018-09-25 Impact factor: 5.562
Authors: Farshid Sepehrband; Giuseppe Barisano; Nasim Sheikh-Bahaei; Ryan P Cabeen; Jeiran Choupan; Meng Law; Arthur W Toga Journal: Sci Rep Date: 2019-08-26 Impact factor: 4.996
Authors: Tobias Granberg; Thomas Moridi; Judith S Brand; Susanne Neumann; Martin Hlavica; Fredrik Piehl; Benjamin V Ineichen Journal: J Neurol Date: 2020-06-13 Impact factor: 4.849